🔓
Sign in as a Member to unlock the full view of SRES.732. · Full carveout list, all affected companies, party defectors, and 30-day trade predictions.
Become a Member$24.50/mo already a Member? Sign in →
SRES.732 · 119TH CONGRESS

A resolution expressing the sense of the Senate that over 25 years of real-world evidence and hundreds of peer-reviewed studies proving that mifepristone is safe and effective should be respected, and law and policy governing access to lifesaving, time-sensitive medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science.

Status
In Committee
Latest Action
2026-05-14
Sponsor
Warren, Elizabeth (D-Massachusetts)
Official Source
Investability
0/100
Stage
COMMITTEE
Related Bills
1
Full Text
Unavailable
Alive
Yes

What This Bill Does · Plain English

Summary
Plain-English summary not yet available for this bill. Check back after our next analysis run.

Action Timeline

2026-05-14
Submitted in Senate
2026-05-14
Referred to the Committee on Health, Education, Labor, and Pensions. (text: CR S2309-2310)

Frequently Asked Questions

Did SRES.732 pass?
SRES.732 is still alive. Current stage: COMMITTEE. Pass likelihood: pending.
Who sponsored SRES.732?
SRES.732 was sponsored by Elizabeth Warren (D-Massachusetts).

Full Bill Text

Full text not yet indexed for this bill. Check Congress.gov for the official text.
🔒 GovGreed Pro · Trading Intelligence on SRES.732 Get Access — $24.50/mo
Loading intelligence layer…
Bill text sourced from GovInfo.gov · public domain · last updated 2026-10-12. Plain-English summary, score breakdown, and trading-intelligence panels are GovGreed-original analysis derived from STOCK Act filings, SEC Form 4 disclosures, FEC contributions, and Senate LDA lobbying reports — all publicly filed federal records. GovGreed is not affiliated with the U.S. Government. Not financial advice. [live render]